What We're Reading: Page 135
Industry reads hand-picked by our editors
Jan 21, 2022
-
Reuters
Alzheimer's patient groups protest U.S. Medicare coverage proposal limiting use of new drugs
-
The New York Times
Deborah Nickerson, Pioneering Genome Researcher, Dies at 67
-
The Wall Street Journal
Unilever Walks Away From Glaxo Consumer-Healthcare Deal
-
STAT
Study casts doubt on how combination cancer therapies work in tandem
Jan 20, 2022
-
CNBC
Fauci says FDA could authorize Pfizer's Covid vaccine for kids under 5 in the next month
-
Bloomberg Law
Merck's $1.4 Billion Insurance Win Splits Cyber From 'Act of War'
-
Bloomberg
One Shot to Protect Against All Covid-19 Variants
-
MIT Technology Review
Going bald? Lab-grown hair cells could be on the way
Jan 19, 2022
-
POLITICO
Abortion pill fight could ensnare Biden’s FDA pick
-
The Wall Street Journal
Drugmaker Gilead Alleges Counterfeiting Ring Sold Its HIV Drugs
-
Bloomberg
A Reckoning Is Coming for Cash-Strapped Biotechs
Jan 18, 2022
-
Reuters
Dove soap maker Unilever signals pursuit of GSK consumer arm; shares fall
-
The New York Times
Halting Progress and Happy Accidents: How mRNA Vaccines Were Made
-
The New Yorker
Jordan Thomas’s Army of Whistle-Blowers
-
Chemical & Engineering News
How Pfizer scientists transformed an old drug lead into a COVID-19 antiviral
Jan 14, 2022
-
The New York Times
Senate Panel OKs Califf Nomination for F.D.A. Chief
-
The Wall Street Journal
Vaccine Makers Pursue Omicron-Targeted Shots That Health Officials Say Might Not Be Needed
-
STAT
Strong new evidence suggests a virus triggers multiple sclerosis
-
C&EN
Sanofi, Amgen sign deals with AI technology developers
Previous
